Newsroom

Animal Free Research UK says 3.4% decrease in animal experiments is wasted opportunity as COVID-19 forces change to medical testing regime

SPT Labtech strengthens company’s connection with Japanese market

Arctoris contributes its capabilities and expertise to the fight against COVID-19

TALLC Corporation announces grant of new SmartCelle patent for enhanced ocular delivery of TA-A001

Byondis’ investigational antibody-drug conjugate SYD985 selected for I-SPY 2 TRIAL™ in early-stage breast cancer

My Personal Therapeutics and Pentavere receive EUREKA Artificial Intelligence/Quantum Therapeutics Funding to support the development of My Personal Therapeutics’s digital therapeutics for Lung Cancer

Freyr launches Covid-19 web platform for manufacturers

PrecisionLife identifies 68 genes associated with high risk of severe COVID-19, suggesting opportunities for genomic biomarkers and new treatment options

Foresight Biosciences & Van Heron Labs form a strategic alliance

EPG Health launches Medthority, a medical website personalised for doctors and tailored for pharma

Strategic alliance between Applied Photophysics and Fluorescence Innovations

Sygnature Discovery boosts senior management team with appointment of Dr Paul Overton

CytoSMART Technologies appoints supervisory board members

Danish robots assisting hard-pressed laboratory technicians with Covid-19 testing work

Sygnature Discovery assists New York Medical College in the fight against COVID-19

New leap forward for SARS-CoV-2 detection

Digital Science reports that preprints account for one quarter of COVID-19 research

Sygnature expands capabilities with acquisition of Alderley Oncology

CytoSMART Technologies announces the launch of the CytoSMART Lux2 Duo Kit

Indica Labs, Octo and Axle work with NIH to launch a global COVID-19 digital pathology repository

Nori Health offers free access to smart chatbot for people with Crohn’s and Colitis during the crisis

Mirror Biologics and Immunovative Therapies announce publication of the technical rationale for development of a universal anti-viral vaccine targeted to protect eldery adults from COVID-19 and any fu

DefiniGEN launches tool for coronavirus-specific intestinal cell research

Digital Science reports that just 10% of global research output relates to the UN’s Sustainable Development Goals

AI-based precision medicine mining of UK Biobank finds 13 human COVID risk genes and identifies 59 drugs with potential to improve survival in severe COVID-19 patients and sepsis

Samplix launches comprehensive service program to address complex genomic questions

Neutec aids in the fight against COVID19 with automated tube fillers

FDA grants Hardy Diagnostics emergency use authorization (EUA) for a rapid antibody test kit for COVID-19

Hardy Diagnostics increases manufacturing to meet demand for COVID-19 related products

Inspirata hosts fireside chat on the Future of Pathology in a post-COVID-19 world

Gemini Bio announces its dedicated effort to help support COVID-19 research

ProteoGenix anounces a new human COVID-19 antibody library to accelerate the discovery of potent and urgently needed solutions

Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19)

NanoPass is joining forces with pharma partners in the fight against the COVID-19 pandemic

ReadCube launches free research pass programme to enable full-text access for COVID-19 researchers

Lonza to host free webinar on using 3D cell culture models to advance respiratory research for diseases like COVID-19

CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers

Sense appoints John Bishop to its Board of Directors

PrecisionLife offers analytics and resource support to COVID-19 coronavirus research community

Sense accelerates instrument-free molecular diagnostic test for COVID-19

Allm Inc. provides diagnostic data set available on “Join” to support the fight against COVID-19

MedEZ™ patient portal helps facilities make an easy transition to remote work

Sygnature Discovery provides state-of-the-art liquid handling machine to UK Government’s COVID-19 testing efforts

BillionToOne announces groundbreaking new COVID-19 test unlocking one million daily tests

Sera Labs and Terratori Technologies getting PPE to those in need

Hamamatsu and KiKo Knowledge Hub join Inspirata’s initiative to offer free pathology resource for healthcare institutions affected by COVID-19

Bardy Diagnostics announces use of the Carnation Ambulatory Monitor Patch to measure QT segments in COVID-19 patients

Volunteer laboratory network launched to expand Covid-19 testing for key workers

Global COVID-19 Clinical Trial Tracker launched by Cytel

VITAL4 offers free healthcare employee screening software to U.S. healthcare facilities impacted by COVID-19

PatientSource offers ‘slimmed down’ version of their EPR software in response to COVID-19 pandemic

PCR Biosystems continues to scale up operations to ensure ongoing availability of COVID-19 test reagents

New COVID-19 at-home test with social distancing ready for validation study

Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal

Scientists on Standby portal launched to support the recruitment of overflow resource for the testing of COVID-19

Hygiena launches all-in-one Listeria, L. monocytogenes detection method

Inceptua announces global license agreement for the commercialization of JETREA®

SciSwipe and SciFlow, two projects aiming to improve workflows in publishing and machine learning, are the latest recipients of the Catalyst Grant award for innovative startups

GenomSys relocates its headquarters to Biopôle, Lausanne

Pathios Therapeutics announces appointment of Dr. Tobias Bopp as the foundational member of its Scientific Advisory Board

AOAC-RI Performance Tested Method Certification modified to include new EnSURE™ Touch Monitoring System

Inceptua and Portola enter exclusive distribution agreement for Ondexxya®

GenomSys strengthens scientific team to expand its reach into the scientific community

Inceptua Appoints New Head of Asia-Pacific, Clinical Trial Services

Applied Photophysics board appoints Tim Flanagan as CEO

Sygnature Discovery strengthens DMPK team

Advanced BioMatrix Acquires HyStem® from Lineage Cell Therapeutics

Exosomics implements NanoFCM’s NanoAnalyzer to provide advanced extracellular vesicles-focused analytical services

Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2

RenaSci bolsters kidney disease and fibrosis capabilities with senior appointment

Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO

The most discussed and shared scientific research of 2019

TTP Labtech announces company name change to SPT Labtech

Inceptua appoints new CEO

Inceptua Medicines Access and Onconova Therapeutics announce pre-approval access collaboration for rigosertib

Inceputua appoints new president to lead North America business development

Tangerine Medical adopts MPEG-G data format for end-to-end genomic data processing

Inceptua and Bendalis enter into exclusive oncology medicine supply agreement for clinical trials

BioCity UK life science start-up report reveals a ‘baby boom’ of new ventures and predicts workspace proliferation

BioCity UK life science start-up report ranks Scotland among the most active areas for emerging businesses

TTP Labtech further advances miniaturised molecular biology with launch of new mosquito genomics

Cells that could lead to new therapies: PromoCell now offers in vitro disease models

Sygnature Discovery invests in high-throughput screening capability

Research on Research Institute (RoRI) launches to enable more strategic, open, diverse, and inclusive research

Sygnature Discovery develops AR molecular visualisation prototype

Sygnature Discovery moves US base to Kendall Square

The increasing importance of failure in supporting modern research

BioCity is the latest investor to back promising 'self care' venture

Samplix launches Xdrop™ – providing PCR-free target enrichment of single molecules

BioCity invests in early-stage precision medicine biotech

GNA Biosolutions closes $13.5M series C financing round backed by a US/EU consortium

BioCity & Oxford AHSN partner to accelerate life science businesses in the golden triangle

Hygiena announces new EnSURE™ Touch monitoring system

My Personal Therapeutics announces funding & secures exclusive Mount Sinai School of Medicine technology license

CytoSMART raises 5.2 million euros for further product innovation and growth

Sygnature Discovery & RenaSci strengthen in vivo pharmacology service-offering

Loop Genomics launches four new Microbiome kits

BioCity invests in tech start-up INCUS Performance

NanoFCM opens European office & centre of excellence for scientific application support

BioCity invests in carbon recycling start-up, Deep Branch Biotechnology

Jackson ImmunoResearch launches secondary antibodies for VHH discovery

Sygnature Discovery announces collaboration with software firm SilcsBio

Senior appointments enhance Sygnature Discovery’s DMPK capabilities

Sygnature Discovery continues strong growth trajectory with two senior appointments

Pathios Therapeutics & Sygnature Discovery partner to boost autoimmune and immuno-oncology drug discovery

Browse more news

Recent releases